Results 91 to 100 of about 1,692 (132)

Jaundice Associated with Norethindrone Acetate Therapy

New England Journal of Medicine, 1962
METHYLTESTOSTERONE has been known to be associated with jaundice and tissue evidence of biliary cholestasis, as mentioned by Werner in 19501 and by subsequent authors.2 Certain modifications of the...
Charles E. Captain Shields   +1 more
openaire   +3 more sources

Pharmacokinetics of norethindrone acetate in women after the insertion of a single subdermal implant releasing norethindrone acetate

Acta Endocrinologica, 1982
Abstract. The metabolic clearance rate (MCR) of norethindrone acetate1 (NETA) and norethindrone (NET) levels in plasma were studied after an iv injection of [3H]NETA in three women before and at 1 week, 1, 2 and 6 months following the insertion of a single silastic subdermal implant releasing microquantities of NETA. No significant change in the MCR of
J.P. Uniyal   +6 more
openaire   +3 more sources

Clinical evaluation of norethindrone acetate in fertility control

American Journal of Obstetrics and Gynecology, 1965
A clinical evaluation of 300 Mexican women accumulating 5902 treatment cycles representing 454 woman-years with 4 mg norethindrone acetate and .05 mg ethinyl estradiol (Anovlar) is presented. Each woman was instructed to take 1 tablet daily for 20 consecutive days beginning on Cycle Day 5. Anovlar was virtually 100% effective.
Edris Rice-Wray   +5 more
openaire   +3 more sources

Norethindrone in Serum After use of an oral Contraceptive Containing Norethindrone Acetate

Acta Obstetricia et Gynecologica Scandinavica, 1983
Abstract. The availability of norethindrone (NET) in serum was studied in 8 women after daily administration of a combination oral contraceptive pill (MinovlarR) containing 1 mg norethindrone acetate (NETA) and 50 μg ethinyl estradiol (EE2) from day 5 to day 25 of the menstrual cycle. The pill was taken daily at 9.30 a.m.
Vimla Laumas   +4 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy